Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P4
Near historical low
vs 5Y Ago
-6.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -47.25% |
| Q3 2025 | 20.47% |
| Q2 2025 | 11.24% |
| Q1 2025 | -23.14% |
| Q4 2024 | -0.10% |
| Q3 2024 | -16.07% |
| Q2 2024 | 12.26% |
| Q1 2024 | -17.39% |
| Q4 2023 | 6.74% |
| Q3 2023 | -24.21% |
| Q2 2023 | -13.56% |
| Q1 2023 | -54.18% |
| Q4 2022 | 9.51% |
| Q3 2022 | -18.73% |
| Q2 2022 | -2.54% |
| Q1 2022 | -3.30% |
| Q4 2021 | 38.51% |
| Q3 2021 | -3.69% |
| Q2 2021 | -28.31% |
| Q1 2021 | 10.95% |
| Q4 2020 | 7.28% |
| Q3 2020 | -21.75% |
| Q2 2020 | -41.43% |
| Q1 2020 | 0.48% |
| Q4 2019 | -9.48% |
| Q3 2019 | -22.70% |
| Q2 2019 | -28.68% |
| Q1 2019 | 0.00% |